| 1 |
22517709 | Effects on the immune system and toxicity of carboplatin/paclitaxel combination chemotherapy in patients with stage III-IV ovarian and non small cell lung cancer and its role in survival and toxicity. | 2012 Jan-Mar |
1 |
| 2 |
10486880 | [Efficiency, safety and tolerability of recombinant human interleukin-3 (rhIL-3) as supportive therapy accompanying dose-intensive carboplatin containing chemotherapy in ovarian cancer with special regard to thrombocytopenia]. | 1999 |
1 |
| 3 |
9762948 | A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group. | 1998 Oct 1 |
1 |
| 4 |
8765425 | Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) Study. | 1996 |
1 |
| 5 |
7705673 | A phase I trial of cyclosphosphamide and carboplatinum combined with interleukin-3 in women with advanced-stage ovarian cancer. | 1995 Mar |
1 |
| 6 |
7884433 | Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: a phase I trial. | 1995 Mar |
2 |
| 7 |
8202718 | Further studies to ameliorate toxicity of carboplatin. | 1994 Apr |
1 |